Search research articles
Contact Us
Filters
Showing results (141-150 of 175) with videos related to
Page
of 18
Sort By:
The American Journal of Surgical Pathology
|
January 31, 2025
Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva
Guy A Williams, Annie A Wu, Henrietta C Eugene, et al.
Vaccine
|
August 6, 2017
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
Kirill Kalnin, Sudha Chivukula, Timothy Tibbitts, et al.
Plos One
|
June 14, 2023
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor
Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam, et al.
Virology
|
May 12, 2005
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
Diana V Pastrana, Ratish Gambhira, Christopher B Buck, et al.
Plos One
|
July 5, 2012
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate
Karen Nieto, Margit Weghofer, Peter Sehr, et al.
Journal of Virology
|
May 19, 2017
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection
Rosie T Jiang, Joshua W Wang, Shiwen Peng, et al.
Cancer Research
|
February 19, 2013
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity
Tae Heung Kang, Chih-Ping Mao, Sung Yong Lee, et al.
Journal of Medicinal Chemistry
|
December 29, 2010
α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells
Martina Bazzaro, Ravi K Anchoori, Mohana Krishna R Mudiam, et al.
Plos One
|
January 16, 2020
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties
Ravi K Anchoori, Marietta Tan, Ssu-Hsueh Tseng, et al.
Vaccines
|
June 27, 2024
Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model
Zhenwei Han, Shen Wang, Ting Mu, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 175) with videos related to
Sort By:
Page
of 18
The American Journal of Surgical Pathology
|
January 31, 2025
Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva
Guy A Williams, Annie A Wu, Henrietta C Eugene, et al.
Vaccine
|
August 6, 2017
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
Kirill Kalnin, Sudha Chivukula, Timothy Tibbitts, et al.
Plos One
|
June 14, 2023
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor
Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam, et al.
Virology
|
May 12, 2005
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
Diana V Pastrana, Ratish Gambhira, Christopher B Buck, et al.
Plos One
|
July 5, 2012
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate
Karen Nieto, Margit Weghofer, Peter Sehr, et al.
Journal of Virology
|
May 19, 2017
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection
Rosie T Jiang, Joshua W Wang, Shiwen Peng, et al.
Cancer Research
|
February 19, 2013
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity
Tae Heung Kang, Chih-Ping Mao, Sung Yong Lee, et al.
Journal of Medicinal Chemistry
|
December 29, 2010
α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells
Martina Bazzaro, Ravi K Anchoori, Mohana Krishna R Mudiam, et al.
Plos One
|
January 16, 2020
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties
Ravi K Anchoori, Marietta Tan, Ssu-Hsueh Tseng, et al.
Vaccines
|
June 27, 2024
Vaccination with a Human Papillomavirus L2 Multimer Provides Broad Protection against 17 Human Papillomavirus Types in the Mouse Cervicovaginal Challenge Model
Zhenwei Han, Shen Wang, Ting Mu, et al.
Page
of 18